Long-term management of elderly patients taking immunosuppressive medications

Aust J Gen Pract. 2020 Mar;49(3):100-106. doi: 10.31128/AJGP-10-19-5137.

Abstract

Background: General practitioners are increasingly likely to encounter elderly patients who are receiving immunosuppressants for the management of autoimmune diseases or solid organ transplants.

Objective: The aim of this article is to provide an overview of the long-term management of the elderly patient treated with immunosuppressants. Recommendations for monitoring, preventing and managing adverse effects of immunosuppressants are summarised.

Discussion: Elderly patients prescribed immunosuppressants may present a number of unique challenges. Immunosenescence, altered pharmacokinetics and the presence of multiple comorbidities can all affect response to immunosuppressants. Through close collaboration with tertiary care providers and regular screening, the general physician is well placed to recognise medication-related complications.

MeSH terms

  • Geriatrics / methods*
  • Geriatrics / trends
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / therapeutic use*
  • Long-Term Care / methods*
  • Long-Term Care / trends
  • Mass Screening / methods

Substances

  • Immunosuppressive Agents